Compounds > lovastatin
Page last updated: 2024-08-23

lovastatin and Lymphoma, B-Cell

lovastatin has been researched along with Lymphoma, B-Cell in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eaton, AF; Eaton, DC; Liu, BC; Lu, XY; Ma, HP; Shen, BZ; Song, X; Thai, TL; Yang, LL; Zhai, YJ1
Ciocca, DR; Cuello Carrión, FD; Gervasoni, SI; Matar, P; Rozados, VR; Scharovsky, OG1
Basak, GW; Bil, J; Bojarski, L; Dabrowska-Iwanicka, A; Engelberts, PJ; Gaciong, Z; Glodkowska, E; Golab, J; Gorska, E; Issat, T; Jakobisiak, M; Kurzaj, Z; Lasek, W; Lekka, M; Mackus, WJ; Makowski, M; Mrowka, P; Nowis, D; Parren, PW; Sinski, M; Stoklosa, T; Warzocha, K; Wasik, M; Wilczek, E; Wilczynski, GM; Winiarska, M1

Other Studies

3 other study(ies) available for lovastatin and Lymphoma, B-Cell

ArticleYear
Lovastatin inhibits human B lymphoma cell proliferation by reducing intracellular ROS and TRPC6 expression.
    Biochimica et biophysica acta, 2014, Volume: 1843, Issue:5

    Topics: Cell Proliferation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Lymphoma, B-Cell; Patch-Clamp Techniques; Reactive Oxygen Species; TRPC Cation Channels; TRPC6 Cation Channel

2014
Hsp25 and Hsp70 in rodent tumors treated with doxorubicin and lovastatin.
    Cell stress & chaperones, 2003,Spring, Volume: 8, Issue:1

    Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Doxorubicin; Drug Resistance, Neoplasm; Endothelium, Vascular; Female; Fibrosarcoma; Heat-Shock Proteins; HSP27 Heat-Shock Proteins; HSP70 Heat-Shock Proteins; Lovastatin; Lymphoma, B-Cell; Mammary Neoplasms, Animal; Mice; Mice, Inbred Strains; Molecular Chaperones; Neoplasm Proteins; Rats; Rats, Inbred Strains

2003
Statins impair antitumor effects of rituximab by inducing conformational changes of CD20.
    PLoS medicine, 2008, Mar-25, Volume: 5, Issue:3

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antibody-Dependent Cell Cytotoxicity; Antigens, CD20; Antineoplastic Agents; B-Lymphocytes; Cell Line, Tumor; Cholesterol; Cytotoxicity, Immunologic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lovastatin; Lymphoma, B-Cell; Membrane Microdomains; Protein Conformation; Rituximab

2008